SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001213900-21-025555
Filing Date
2021-05-11
Accepted
2021-05-11 11:26:13
Documents
1
Effectiveness Date
2021-05-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6897
  Complete submission text file 0001213900-21-025555.txt   7955
Mailing Address 1013 CENTRE ROAD SUITE 403-B WILMINGTON DE 19805
Business Address 670-21,SANNAE-RO, SANNAE-MYEON MIRYANG-SI, GYEONGSANGNAM-DO M5 50414 780-448-1400
ONCOQUEST PHARMA USA, INC (Filer) CIK: 0001839861 (see all company filings)

IRS No.: 852185480 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-398916 | Film No.: 21910228